Cargando…

Real-Life Experience of Efficacy and Safety of Bilastine in the Refractory Cases of Chronic Spontaneous Urticaria and its Effect on the Quality of Life of Patients

INTRODUCTION: Second-generation H1-antihistamines (SGAHs) are the mainstay of treatment of chronic spontaneous urticaria (CSU). Bilastine, newer non-sedating SGAHs, was recently introduced in India after the approval of the Drugs Controller General of India. There is a paucity of evidence about the...

Descripción completa

Detalles Bibliográficos
Autores principales:	De, Abhishek, Godse, Kiran, Dhoot, Dhiraj, Sarda, Aarti
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8208247/ https://www.ncbi.nlm.nih.gov/pubmed/34188271 http://dx.doi.org/10.4103/ijd.IJD_771_20

Ejemplares similares

Experience with bilastine in the management of urticaria: Original Real-world cases of Bilastine In Treatment (ORBIT) in Asia
por: Cheong, Wai Kwong, et al.
Publicado: (2022)

Bilastine for allergic rhinoconjunctivitis, urticaria
Publicado: (2022)

The safety and tolerability profile of bilastine for chronic urticaria in children
por: Papadopoulos, Nikolaos G., et al.
Publicado: (2019)

A Comparative, Three-Arm, Randomized Clinical Trial to Evaluate the Effectiveness and Tolerability of Bilastine vs Fexofenadine vs Levocetirizine at the Standard Dose and Bilastine vs Fexofenadine at Higher Than the Standard Dose (Up-Dosing) vs Levocetirizine and Hydroxyzine (in Combination) in Patients with Chronic Spontaneous Urticaria
por: Shah, Bela, et al.
Publicado: (2022)

Comparative efficacy of bilastine, levocetirizine and desloratadine updosing in chronic urticaria
por: Staevska, Maria T
Publicado: (2016)

Real-World Insight on Apremilast Therapy in Patients with Plaque Psoriasis: Indian Experience
por: De, Abhishek, et al.
Publicado: (2020)

One‐year safety and efficacy study of bilastine treatment in Japanese patients with chronic spontaneous urticaria or pruritus associated with skin diseases
por: Yagami, Akiko, et al.
Publicado: (2016)

Comparative study of efficacy and safety of cetirizine and bilastine in patients of chronic spontaneous urticaria: Open-label, randomized, parallel-group study
por: Sinha, Vishakha V., et al.
Publicado: (2023)

Critical appraisal of bilastine for the treatment of allergic rhinoconjunctivitis and urticaria
por: Sadaba, Belen, et al.
Publicado: (2013)

OMALIZUMAB IN TREATMENT-RESISTANT CHRONIC SPONTANEOUS URTICARIA
por: Godse, Kiran V
Publicado: (2011)

EBASTINE IN CHRONIC SPONTANEOUS URTICARIA IN HIGHER DOSES
por: Godse, Kiran V
Publicado: (2011)

Treatment of Refractory Chronic Urticaria
por: Mehta, Aayushi, et al.
Publicado: (2015)

Apremilast Coadministered with Secukinumab for Safe and Effective Control of Psoriasis with Resultant Reduction of Maintenance Dose of the Biologic
por: De, Abhishek, et al.
Publicado: (2019)

Pharmacokinetics and safety of bilastine in children aged 6 to 11 years with allergic rhinoconjunctivitis or chronic urticaria
por: Rodríguez, Mónica, et al.
Publicado: (2020)

Up-dosing with bilastine results in improved effectiveness in cold contact urticaria
por: Krause, K, et al.
Publicado: (2013)

Role of bilastine in the management of allergic rhinitis and urticaria: an Asia-Pacific consensus statement
por: Mösges, Ralph, et al.
Publicado: (2016)

Treatment of allergic rhinitis and urticaria: a review of the newest antihistamine drug bilastine
por: Wang, Xue Yan, et al.
Publicado: (2016)

Fexofenadine in higher doses in chronic spontaneous urticaria
por: Godse, Kiran V., et al.
Publicado: (2010)

Subcutaneous Autologous Serum Therapy in Chronic Spontaneous Urticaria
por: Godse, Kiran Vasant, et al.
Publicado: (2017)

Urticaria Meter
por: Godse, Kiran V
Publicado: (2012)

The incidence of depression and anxiety disorders in spontaneous chronic urticaria patients
por: Bangera, Anushree, et al.
Publicado: (2023)

Bilastine: A New Nonsedating Oral H1 Antihistamine for Treatment of Allergic Rhinoconjunctivitis and Urticaria
por: Wolthers, Ole D.
Publicado: (2013)

Efficacy and safety of omalizumab in Chinese patients with anti‐histamine refractory chronic spontaneous urticaria
por: Yuan, Weiru, et al.
Publicado: (2022)

PATCH TESTING IN CHRONIC URTICARIA
por: Godse, Kiran V
Publicado: (2009)

OLOPATADINE IN CHRONIC IDIOPATHIC URTICARIA
por: Godse, Kiran V
Publicado: (2009)

CHRONIC URTICARIA AND TREATMENT OPTIONS
por: Godse, Kiran Vasant
Publicado: (2009)

The role of prednisolone in acute urticaria management
por: Godse, Kiran
Publicado: (2015)

Real-life clinical practice with omalizumab in 134 patients with refractory chronic spontaneous urticaria: a single-center experience()
por: Akdaş, Elçin, et al.
Publicado: (2023)

Malaria Presenting as Urticaria
por: Godse, Kiran V, et al.
Publicado: (2012)

Efficacy of switching to bilastine, a histamine H1 receptor antagonist, in patients with chronic spontaneous urticaria (H1-SWITCH): study protocol for a randomized controlled trial
por: Fukunaga, Atsushi, et al.
Publicado: (2020)

Multicentric and Observational Study of Omalizumab for Chronic Spontaneous Urticaria in Real-Life in Colombia
por: García-Gómez, Elizabeth, et al.
Publicado: (2022)

USE OF A BALLPOINT PEN IN THE DIAGNOSIS OF PHYSICAL URTICARIA
por: Godse, Kiran V
Publicado: (2011)

Efficacy and Safety of Bilastine in the Treatment of Allergic Rhinitis: A Systematic Review and Meta-analysis
por: Singh Randhawa, Aranjit, et al.
Publicado: (2022)

Omalizumab's efficacy and safety against chronic spontaneous urticaria
por: Özdemir, Öner
Publicado: (2023)

Autologous Serum Therapy in Chronic Urticaria
por: Patil, Sharmila, et al.
Publicado: (2013)

Disease-specific impairment of the quality of life in adult patients with chronic spontaneous urticaria
por: Choi, Won-Sun, et al.
Publicado: (2018)

Efficacy and Safety of Biologic Agents in Chronic Urticaria, Asthma and Atopic Dermatitis – A Real-life Experience
por: Abuzakouk, Mohamed, et al.
Publicado: (2020)

Recurrent Facial Urticaria Following Herpes Simplex Labialis
por: Zawar, Vijay, et al.
Publicado: (2012)

Bilastine in allergic rhinoconjunctivitis and urticaria: a practical approach to treatment decisions based on queries received by the medical information department
por: Leceta, Amalia, et al.
Publicado: (2017)

Efficacy and safety of omalizumab against chronic spontaneous urticaria: Real-world study from China()
por: Wang, Ao, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_hlua3p9tual7tn0dsf3nqe90ci